Universitätsklinikum Essen

Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine (2019) Schlenk RF, Weber D, Herr W, Wulf G, Salih HR, Derigs HG, Kuendgen A, et al. Journal article Association of an initial Exanthem with Vemurafenib and Cobimetinib for a better Therapeutic Success in metastatic Melanoma Patients (2019) Kaehler K, Bohne AS, Gutzmer R, Satzger I, Meier F, Reinhardt L, Zimmer L, et al. Conference contribution Lipase Elevations and Diabetes under Checkpoint Inhibition - Experience in 80 Patients (2019) Weihkopf D, Satzger I, Zimmer L, Eigentler T, Haessel J, Heinzerling L, Herbst R, et al. Conference contribution Characterization of Patients with inoperable malignant Stage IIIB-D Melanoma (2019) Zaremba A, Weishaupt C, Glutsch V, Schilling B, Loquai C, Rafei-Shamsabadi D, Meiss F, et al. Conference contribution Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma (2019) Jain P, Finger PT, Damato B, Coupland SE, Heimann H, Kenawy N, Brouwer NJ, et al. Journal article Reproducibility and Repeatability of MR Fingerprinting Relaxometry in the Human Brain (2019) Koerzdoerfer G, Kirsch R, Liu K, Pfeuffer J, Hensel B, Jiang Y, Ma D, et al. Journal article IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency Reactivation (2019) Hotter D, Bosso M, Jønsson KL, Krapp C, Stürzel CM, Das A, Littwitz-Salomon E, et al. Journal article Clinical courses and complications of young adults with Autosomal Recessive Polycystic Kidney Disease (ARPKD) (2019) Burgmaier K, Kilian S, Bammens B, Benzing T, Billing H, Buescher A, Galiano M, et al. Journal article Dabigatran for prevention of stroke after embolic stroke of undetermined source (2019) Diener HC, Sacco RL, Donald Easton J, Granger CB, Bernstein RA, Uchiyama S, Kreuzer J, et al. Journal article Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - A randomized, double-blind, placebo-controlled trial (2019) Dittrich S, Graf E, Trollmann R, Neudorf U, Schara U, Heilmann A, Von Der Hagen M, et al. Journal article